XORTX Therapeutics Inc. - Common Stock (XRTX)

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

XORTX Therapeutics just reported results for the second quarter of 2024.

XORTX Therapeutics just reported results for the first quarter of 2024.

--News Direct--

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to know about this morning!

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares surged 91.2% to $0.2180 in pre-market trading after falling 10% on Monday.

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Okta stock is still falling on Monday as the company's shares suffer after it revealed a data breach of customer information.

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell 0.33% to 12,940.56. The S&P 500 also fell, dropping, 0.33% to 4,210.14.

Xortx Therapeutics stock is falling on Monday as the pharmaceutical company's shares retreat from a massive rally on Friday.

Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 151.7% to $0.2190 in pre-market trading after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub.

It's time to start off the workweek with a detailed breakdown of the biggest pre-market stock movers for Monday morning!

Xortx Therapeutics Inc. (NASDAQ: XRTX) shares are trading higher Friday on unusually heavy trading volume. Here's a look at what's going on:

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.

Solar stocks are down on Friday and investors can look to Deutsche Bank are the reason for the slump in the sector today.

U.S. stocks traded lower this morning, with the Dow Jones index falling around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.17% to 33,357.23 while the NASDAQ fell 0.18% to 13,161.86. The S&P 500 also fell, dropping, 0.18% to 4,270.49.